skip to Main Content

Solupore®

non-viral delivery platform for cell engineering

The Solupore non-viral delivery system enables the next generation of cell therapies through unparalleled cell health and superior cell functionality, expanding the possibilities for complex editing and challenging cargo delivery. Easy to integrate into existing GMP processes, Solupore accelerates the translation of life-saving therapies to patients.

MUC with Temp
Avectas Opening Ceremony

About Avectas

Avectas is accelerating the future of cell therapy with a flexible, easy-to-integrate delivery platform that manufactures healthier and more functional cells for patients. Excelling at complex editing and challenging cargo delivery, the Avectas non-viral delivery platform ensures the next generation of cell therapies can be realized.

Find Out More
Our Technology solupore

Our Technology

Solupore®

check box
Automated, reproducible transfection

A closed simple, and robust process where cells maintained at a normal physiological level

check box
Versatile delivery of cargo

Transfection of a broad range of cargo and gene editing tools including mRNA, CRISPR/Cas9 and plasmids

check box
Full GMP support by 2H 2024

GMP instrument on existing platform supported by appropriate documentation of regulatory fillings

check box
Commercialization

Partner access to technology under co-development and licensing agreements

Discover

Find out more about our exciting upcoming events at Avectas

Upcoming Events

ISSCR 2024 Hamburg Germany
ISSCR 2024
July 10, 2024 - July 13, 2024
|
Hamburg, Germany
ISSCR 2024
CAR-TCR Picture 24
CAR-TCR Summit
September 17, 2024 - September 20, 2024
|
Boston
CAR-TCR Summit
Cell & Gene Meeting On The Mesa
Cell & Gene Meeting on the Mesa
October 7, 2024 - October 9, 2024
|
Phoenix, Arizona
Cell & Gene Meeting on the Mesa

Our Partners

Partnerships are essential to ensure better patient outcomes, and we are actively seeking to engage with companies and researchers who are developing these lifesaving gene-modified cell therapy products. Find our current list on our partner page.

Contact Avectas

Partnerships are essential to ensure better patient outcomes, and we are actively seeking to engage with companies and researchers who are developing these lifesaving gene modified cell therapy products. If you would like to learn more about working with Avectas and our cell engineering technology, get in touch with us.

Join Mailing List

Learn about our non-viral delivery platform including application notes, upcoming webinars, new resources and events.